[Heart failure with preserved ejection fraction].
Explore this paper's citation graph
Summary
The treatment of heart failure with preserved ejection fraction lacks clear evidence of mortality reduction, diuretics are recommended to remove symptoms, ACE inhibitors or sartans and beta-blockers to improve the prognosis.
- Type
- article
- Published
- 2018-01-01
- Cited by
- 0
- References
- 30
- OpenAlex
- https://openalex.org/W2538662566
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:38539420
Keywords
Ejection fraction, Heart failure, Cardiology, Internal medicine, Medicine
References
- Cardiovascular protection using beta-blockers: a critical review of the evidence.
- More ‘malignant’ than cancer? Five‐year survival following a first admission for heart failure
- Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
- European Guidelines on Cardiovascular Disease Prevention
- Diuretics in heart failure.
- Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials.
- Perindopril for elderly people with chronic heart failure: the PEP‐CHF study
- Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.
- Irbesartan in patients with heart failure and preserved ejection fraction.
- New Doppler echocardiographic applications for the study of diastolic function.
- Recommendations for the evaluation of left ventricular diastolic function by echocardiography.
- Outcome of heart failure with preserved ejection fraction in a population-based study.
- Risk of venous thromboembolism in patients hospitalized with heart failure.
- The incidence of ischemic stroke in chronic heart failure: a meta-analysis.
- Survival of patients with a new diagnosis of heart failure: a population based study
- &bgr;-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction: Post Hoc Analysis From the CHARISMA Trial
- Clinical epidemiology of heart failure
- Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-Analysis
- [Guidelines for the diagnosis and treatment of chronic heart failure].
- Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
Cited by
No citing papers recorded for this paper.
Related papers
- Increased stroke risk in atrial fibrillation patients with heart failure: does ejection fraction matter?
- MORTALITY AND MORBIDITY IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION EXPOSED TO DIGOXIN: COMPREHENSIVE DATA ACCORDING TO ATRIAL FIBRILLATION IN 23,708 PATIENTS FROM THE SWEDISH HEART FAILURE REGISTRY
- Beta-blockers are effective in congestive heart failure patients with atrial fibrillation.
- Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and Outcomes
- Comparing New Onset Heart Failure with Reduced Ejection Fraction and New Onset Heart Failure with Preserved Ejection Fraction: An Epidemiologic Perspective
- Growing Evidence Linking Microvascular Dysfunction With Heart Failure With Preserved Ejection Fraction
- [Heart failure with preserved ejection fraction (diastolic heart failure)].
- A comparison of clinical outcomes following atrial fibrillation ablation for heart failure patients with preserved or reduced left ventricular function: A systematic review and meta-analysis
- Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction.